手機版
化工儀器網手機版
化工儀器網小程序
官方微信
公眾號：chem17
掃碼關注視頻號
達比加群酯是zui前沿的新一代口服抗凝藥物直接凝血酶抑制劑(DTIs)，用于預防非瓣膜性房顫患者的卒中和全身性栓塞。達比加群酯可提供有效的、可預測的、穩定的抗凝效果，同時較少發生藥物相互作用，無藥物食物相互作用，無需常規進行凝血功能監測或劑量調整。
深圳遠揚化學可提供達比加群酯申報所用全套雜質， 進口國產均有銷售，隨貨附CoA證書，HNMR，MS，HPLC圖譜，純度符合申報要求。另外，我司有自主實驗室，可提供達比加群酯雜質定制服務，如以上列表無您需要的雜質，我司詳詢（請點擊本頁標題下方，進入該公司展臺查看我司信息）。
| Dabigatran | 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | C25H25N7O3 | 471.51 |
| Dabigatran Impurity 1 | ethyl 3-(2-(iminomethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C20H21N5O3 | 379.41 |
| Dabigatran Impurity 2 | 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | C32H37N7O5 | 599.68 |
| Dabigatran Impurity 3 | ethyl 3-(1-methyl-3-oxo-N-(pyridin-2-yl)-1,2,3,4-tetrahydroquinoxaline-6-carboxamido)propanoate | C20H22N4O4 | 382.41 |
| Dabigatran Impurity 4 | methyl 3-(2-(hydroxymethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C19H20N4O4 | 368.39 |
| Dabigatran Impurity 5 | 3-(2-(chloromethyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | C18H17ClN4O3 | 372.81 |
| Dabigatran Impurity 6 | diethyl 3,3'-((2,2'-(oxybis(methylene))bis(1-methyl-1H-benzo[d]imidazole-5,5'-carbonyl))bis(pyridin-2-ylazanediyl))dipropanoate | C40H42N8O7 | 746.32 |
| Dabigatran Impurity 7 | hexyl (imino(4-(((1-methyl-5-(pyridin-2-ylcarbamoyl)-1H-benzo[d]imidazol-2-yl)methyl)amino)phenyl)methyl)carbamate | C29H33N7O3 | 527.62 |
| Dabigatran Impurity 8 | (Z)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid | C32H37N7O5 | 599.68 |
| Dabigatran Impurity 9 | ethyl 3-(2-(((4-(((hexyloxy)carbonyl)carbamoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C34H40N6O6 | 628.72 |
| Dabigatran Impurity 10 | (Z)-ethyl 3-(2-(((4-(N'-((hexan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C34H41N7O5 | 627.73 |
| Dabigatran Impurity 11 | (Z)-ethyl 3-(2-(((4-(N'-((hexan-3-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C34H41N7O5 | 627.73 |
| Dabigatran Impurity 12 | ethyl 3-(1,2-dimethyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C20H22N4O3 | 366.41 |
| Dabigatran Impurity 13 | ethyl 3-(1-methyl-2-oxo-N-(pyridin-2-yl)-2,3-dihydro-1H-benzo[d]imidazole-5-carboxamido)propanoate | C19H20N4O4 | 368.39 |
| Dabigatran Impurity 14 | (Z)-ethyl 2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate | C26H33N5O4 | 479.57 |
| Dabigatran Impurity 15 | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C27H26N6O3 | 482.53 |
| Dabigatran Impurity 16 | ethyl 3-(2-(((4-(ethoxy(imino)methyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | C29H32N6O4·HCl | 565.06 |
| Dabigatran Impurity 17 | (Z)-methyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C33H39N7O5 | 613.71 |
| Dabigatran Impurity 18 | (Z)-hexyl (amino(4-(((5-((3-amino-3-oxopropyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)phenyl)methylene)carbamate | C32H38N8O4 | 598.70 |
| Dabigatran Impurity 19 | ethyl 3-(2-(((4-carbamoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | C27H28N6O4 | 500.55 |
| Dabigatran Impurity 20 | ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | C27H29N7O3·HCl | 536.03 |
| Dabigatran Impurity 21 | ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | C18H22N4O3 | 342.39 |
| Dabigatran Impurity 22 | ethyl 3-(3-(2-((4-cyanophenyl)amino)acetamido)-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate | C27H28N6O4 | 500.55 |
達比加群酯雜質新藥申報用結構式歡迎我司獲取~
免責聲明
- 凡本網注明“來源：化工儀器網”的所有作品，均為浙江興旺寶明通網絡有限公司-化工儀器網合法擁有版權或有權使用的作品，未經本網授權不得轉載、摘編或利用其它方式使用上述作品。已經本網授權使用作品的，應在授權范圍內使用，并注明“來源：化工儀器網”。違反上述聲明者，本網將追究其相關法律責任。
- 本網轉載并注明自其他來源（非化工儀器網）的作品，目的在于傳遞更多信息，并不代表本網贊同其觀點和對其真實性負責，不承擔此類作品侵權行為的直接責任及連帶責任。其他媒體、網站或個人從本網轉載時，必須保留本網注明的作品第一來源，并自負版權等法律責任。
- 如涉及作品內容、版權等問題，請在作品發表之日起一周內與本網聯系，否則視為放棄相關權利。
采購中心